These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28111294)

  • 1. Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study.
    Huwyler T; Lenggenhager L; Abbas M; Ing Lorenzini K; Hughes S; Huttner B; Karmime A; Uçkay I; von Dach E; Lescuyer P; Harbarth S; Huttner A
    Clin Microbiol Infect; 2017 Jul; 23(7):454-459. PubMed ID: 28111294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study.
    Boschung-Pasquier L; Atkinson A; Kastner LK; Banholzer S; Haschke M; Buetti N; Furrer DI; Hauser C; Jent P; Que YA; Furrer H; Babouee Flury B
    Clin Microbiol Infect; 2020 Mar; 26(3):333-339. PubMed ID: 31284030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of imipenem and the incidence of toxicity and failure in hospitalized patients: a retrospective cohort study.
    Bricheux A; Lenggenhager L; Hughes S; Karmime A; Lescuyer P; Huttner A
    Clin Microbiol Infect; 2019 Mar; 25(3):383.e1-383.e4. PubMed ID: 30528370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective monitoring of cefepime in intensive care unit adult patients.
    Chapuis TM; Giannoni E; Majcherczyk PA; Chioléro R; Schaller MD; Berger MM; Bolay S; Décosterd LA; Bugnon D; Moreillon P
    Crit Care; 2010; 14(2):R51. PubMed ID: 20359352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-times-weekly, post-dialysis cefepime therapy in patients on maintenance hemodialysis: a retrospective study.
    Descombes E; Martins F; Hemett OM; Erard V; Chuard C
    BMC Pharmacol Toxicol; 2016 Feb; 17():4. PubMed ID: 26846675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous versus intermittent infusion of cefepime in neurosurgical patients with post-operative intracranial infections.
    Huang H; Huang S; Zhu P; Xi X
    Int J Antimicrob Agents; 2014 Jan; 43(1):68-72. PubMed ID: 24139880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ceftazidime and cefepime in burn patients: the importance of age and creatinine clearance.
    Conil JM; Georges B; Lavit M; Seguin T; Tack I; Samii K; Chabanon G; Houin G; Saivin S
    Int J Clin Pharmacol Ther; 2007 Oct; 45(10):529-38. PubMed ID: 17966838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia.
    Aitken SL; Altshuler J; Guervil DJ; Hirsch EB; Ostrosky-Zeichner LL; Ericsson CD; Tam VH
    Int J Antimicrob Agents; 2015 May; 45(5):541-4. PubMed ID: 25665726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study.
    Huttner A; Von Dach E; Renzoni A; Huttner BD; Affaticati M; Pagani L; Daali Y; Pugin J; Karmime A; Fathi M; Lew D; Harbarth S
    Int J Antimicrob Agents; 2015 Apr; 45(4):385-92. PubMed ID: 25656151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity.
    Rhodes NJ; Kuti JL; Nicolau DP; Neely MN; Nicasio AM; Scheetz MH
    J Infect Chemother; 2016 Feb; 22(2):78-83. PubMed ID: 26712584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring when using cefepime in continuous renal replacement therapy: seizures associated with cefepime.
    Smith NL; Freebairn RC; Park MA; Wallis SC; Roberts JA; Lipman J
    Crit Care Resusc; 2012 Dec; 14(4):312-5. PubMed ID: 23230881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia.
    Boselli E; Breilh D; Duflo F; Saux MC; Debon R; Chassard D; Allaouchiche B
    Crit Care Med; 2003 Aug; 31(8):2102-6. PubMed ID: 12973166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study to determine the cefepime-induced neurotoxicity threshold in hospitalized patients.
    Lau C; Marriott D; Gould M; Andresen D; Reuter SE; Penm J
    J Antimicrob Chemother; 2020 Mar; 75(3):718-725. PubMed ID: 31711216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective assessment of breakthrough infections and neurotoxicity and their association with cefepime trough concentrations in patients with febrile neutropenia.
    Gijsen M; Bekkers B; Maertens J; Lagrou K; Desmet S; Dreesen E; Peetermans WE; Debaveye Y; Spriet I
    Int J Antimicrob Agents; 2022 Jan; 59(1):106472. PubMed ID: 34757136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating outcomes of alternative dosing strategies for cefepime: a qualitative systematic review.
    Burgess SV; Mabasa VH; Chow I; Ensom MH
    Ann Pharmacother; 2015 Mar; 49(3):311-22. PubMed ID: 25575975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefepime versus cefpirome: the importance of creatinine clearance.
    Lipman J; Wallis SC; Boots RJ
    Anesth Analg; 2003 Oct; 97(4):1149-1154. PubMed ID: 14500173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function.
    Lamoth F; Buclin T; Pascual A; Vora S; Bolay S; Decosterd LA; Calandra T; Marchetti O
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4360-7. PubMed ID: 20625153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Jakob SM; Levkovich BJ; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Roberts JA; Shekar K; Fraser JF
    Int J Antimicrob Agents; 2021 Dec; 58(6):106466. PubMed ID: 34688834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous infusion versus intermittent administration of cefepime in patients with Gram-negative bacilli bacteraemia.
    Jaruratanasirikul S; Sriwiriyajan S; Ingviya N
    J Pharm Pharmacol; 2002 Dec; 54(12):1693-6. PubMed ID: 12542901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.